Contribution of myeloid and lymphoid host cells to the curative outcome of mouse sarcoma treatment by photodynamic therapy

Coffman, 1981, B220: a B cell-specific member of the T200 glycoprotein family, Nature, 289, 681, 10.1038/289681a0 de Wree, 1996, Evidence for an important role of neutrophils in the efficacy of photodynamic therapy in vivo, Cancer Res., 56, 2908 de Wree, 1997, Role of interleukin 1 and granulocyte colony-stimulating factor in Photofrin-based photodynamic therapy of rat rhabdomyosarcoma tumors, Cancer Res., 57, 2555 Dougherty, 1998, Photodynamic therapy, J. Natl. Cancer Inst., 90, 889, 10.1093/jnci/90.12.889 Evans, 1990, Effect of photodynamic therapy on tumor necrosis factor production by murine macrophages, J. Natl. Cancer Inst., 82, 34, 10.1093/jnci/82.1.34 Frey, 1996, Role of host antigen receptor-bearing and antigen receptor-negative cells in immune response to rat adenocarcinoma 13762, J. Immunol., 156, 3841, 10.4049/jimmunol.156.10.3841 Gallin, 1989, Inflammation, 721 Gollnick, 1997, Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo, Cancer Res., 57, 3904 Henderson, 1992, How does photodynamic therapy work?, Photochem. Photobiol., 55, 145, 10.1111/j.1751-1097.1992.tb04222.x Hock, 1991, Interleukin 7 induces CD4+ T cell-dependent tumour rejection, J. Exp. Med., 174, 1291, 10.1084/jem.174.6.1291 Korbelik, 1996, Induction of tumour immunity by photodynamic therapy, J. Clin. Laser Med. Surg., 14, 329, 10.1089/clm.1996.14.329 Korbelik, 1998, The role of nitric oxide in the response of cancerous lesions to photodynamic therapy, 267 Korbelik, 1996, Photosensitizer distribution and photosensitized damage of tumor tissues, 229 Korbelik, 1996, The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy, Cancer Res., 56, 5647 Korbelik, 1997, Macrophage-directed immunotherapy as adjuvant to photodynamic therapy of cancer, Br. J. Cancer, 75, 202, 10.1038/bjc.1997.34 Korbelik, 1998, Enhancement of tumor response to photodynamic therapy by adjuvant mycobacterium cell wall treatment, J. Photochem. Photobiol. B: Biol., 44, 151, 10.1016/S1011-1344(98)00138-9 Krosl, 1995, Induction of immune cell infiltration into murine SCCVII tumour by Photofrin-based photodynamic therapy, Br. J. Cancer, 71, 549, 10.1038/bjc.1995.108 Krosl, 1996, Potentiation of photodynamic therapy-elicited antitumor response by localized treatment with granulocyte-macrophage colony-stimulating factor, Cancer Res., 56, 3281 Levy, 1975, Effects of intravenous silica on immune and non-immune functions of the murine host, J. Immunol., 115, 41, 10.4049/jimmunol.115.1.41 Nseyo, 1990, Urinary cytokines following photodynamic therapy for bladder cancer. A preliminary report, Urology, 36, 167, 10.1016/0090-4295(90)80220-H Pekarek, 1995, Inhibition of tumour growth by elimination of granulocytes, J. Exp. Med., 181, 435, 10.1084/jem.181.1.435 Rockwell, 1972, Characteristics of a serially transplanted mouse mammary tumor and its tissue-culture-adapted derivative, J. Natl. Cancer Inst., 49, 735 Sarmiento, 1982, Cloned T lymphocytes and monoclonal antibodies as probes for cell surface molecules active in T cell-mediated cytolysis, Immunol. Rev., 68, 135, 10.1111/j.1600-065X.1982.tb01063.x Symington, 1982, Lyb-8.2: a new cell antigen defined and characterized with a monoclonal antibody, Immunogenetics, 16, 381, 10.1007/BF00372098 Zubler, 1984, Activated B cells express receptors for, and proliferate in response to, pure interleukin 2, J. Exp. Med., 160, 1170, 10.1084/jem.160.4.1170